TY - JOUR
T1 - Concentrations of unconjugated estrone, estradiol, androstenedione and testosterone in ovarian and peripheral venous plasma in women
T2 - The effects of steroid contraceptives
AU - Weisz, Judith
AU - Lloyd, Charles W.
AU - Lobotsky, Julia
AU - Pupkin, Marcos
AU - Zanartu, Juan
AU - Puga, Juan
PY - 1973/8
Y1 - 1973/8
N2 - The concentrations of unconjugated estrone, estradiol, testosterone and androstenedione were measured in peripheral and ovarian venous plasma collected from 17 women treated with one of the following contraceptives: intramuscular medroxyprogesterone, oral chlormadinone or ethynodiol diacetate with mestranol. Estradiol in both ovarian and peripheral plasma was low; in all cases it was below the mean for 18 normal women. In ovarian venous plasma the levels of estrone were higher than those of estradiol in 7 of the 11 women treated with chlormadinone or ethynodiol and mestranol while in the 5 women treated with medroxyprogesterone estradiol was higher than estrone, as is found in untreated women. The principal change in the C19 steroids was a decreased concentration of androstenedione in ovarian venous plasma. This was especially evident in women treated with ethynodiol and mestranol. Testosterone levels were comparable to those of untreated subjects.
AB - The concentrations of unconjugated estrone, estradiol, testosterone and androstenedione were measured in peripheral and ovarian venous plasma collected from 17 women treated with one of the following contraceptives: intramuscular medroxyprogesterone, oral chlormadinone or ethynodiol diacetate with mestranol. Estradiol in both ovarian and peripheral plasma was low; in all cases it was below the mean for 18 normal women. In ovarian venous plasma the levels of estrone were higher than those of estradiol in 7 of the 11 women treated with chlormadinone or ethynodiol and mestranol while in the 5 women treated with medroxyprogesterone estradiol was higher than estrone, as is found in untreated women. The principal change in the C19 steroids was a decreased concentration of androstenedione in ovarian venous plasma. This was especially evident in women treated with ethynodiol and mestranol. Testosterone levels were comparable to those of untreated subjects.
UR - http://www.scopus.com/inward/record.url?scp=0015829697&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0015829697&partnerID=8YFLogxK
U2 - 10.1210/jcem-37-2-254
DO - 10.1210/jcem-37-2-254
M3 - Article
C2 - 4720072
AN - SCOPUS:0015829697
SN - 0021-972X
VL - 37
SP - 254
EP - 260
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 2
ER -